You just read:

GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases

News provided by

GNS Healthcare

Aug 10, 2017, 06:30 ET